Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 September 2024 | Story Leonie Bolleurs | Photo Stephen Collett
Prof Jeremy Smith
Prof Jeremy Smith, Adjunct Professor in the Department of Architecture, recently delivered his inaugural lecture on the UFS Bloemfontein Campus.

A few days after the annual Sophia Gray lecture, the Department of Architecture at the University of the Free State (UFS) hosted the inaugural lecture of Prof Jeremy Smith.

Prof Smith, the Design Director of Irving Smith Architects in New Zealand and an Adjunct Professor in the UFS Department of Architecture, is known for his innovative approach to architecture that emphasises sustainability and the relationship between buildings and their natural surroundings.

Earlier this year, he partnered with RTA Studio – an architectural firm based in Auckland, New Zealand – and won the prestigious Dubai International Best Practices Award for Sustainable Development in the category of the Most Beautiful, Innovative and Iconic Building with the entry: The ‘Scion Innovation Hub, Te Whare Nui O Tuteata.

A changing climate

Themed Being Finished is Finished, the lecture attracted a diverse audience of architects, industry stakeholders, academics, students, and the general public. Prof Vasu Reddy, Deputy Vice-Chancellor: Research and Internationalisation, welcomed Prof Smith and the attendees. He congratulated Prof Smith on this milestone, highlighting that a professor’s work often represents the beginning of much unfinished business. He noted that the UFS is proud to host such lectures, which celebrate and acknowledge excellence in research and practice.

Prof Paul Oberholster, Dean of the Faculty of Natural and Agricultural Sciences, introduced Prof Smith, praising his impressive career and the numerous national and international awards he has received.

Prof Smith’s lecture focused on the evolving relationship between architecture and the landscape, particularly in New Zealand, where only a quarter of the original forests remain. “We know our climate is changing. In New Zealand we massively made landscape; landscape is everything. Modernism has asked us to use the lawnmower,” he remarked.

He believes in the importance of architecture that adapts and evolves within its natural surroundings, rather than imposing new landscapes. He introduced the concept of ‘soft architecture’, which involves designing buildings that fit into the changing landscape. This approach allows for a sustainable relationship between architecture and nature, ensuring that buildings enhance rather than dominate their environment.

He illustrated this philosophy with a project, the ‘Bach with Two Roofs’ house, which was damaged by a cyclone in 2014. The storm altered the surrounding landscape, and rather than simply repairing the house, Prof Smith redesigned it in a flexible and adaptive manner that might accommodate environmental change. This project demonstrated how buildings can be refurnished to adapt to a shift in the landscape, ultimately coexisting with and responding to the natural world.

“From life in the forest, the landscape shifted – the sun was hotter, the wind was stronger. Our building has lost its fit to the landscape. Refurnishing it, we need to acknowledge that this time a new forest will grow. It will be a stronger forest – it will be indigenous and will grow in relation to the building. In this shifting landscape, it’s not the landscape that needs to be refurnished. It is the building.”

Doing more with less

Prof Smith also discussed two award-winning projects: the ‘Te Whare Nui O Tuteata’ project and the ‘Feather House’. Both projects are examples of his commitment to sustainability and adaptive design – doing more with less.

The ‘Te Whare Nui O Tuteata’ project, part of the New Zealand government’s SCION Timber Research Institute, uses a diagrid timber structure that reduces material usage and allows the building to integrate seamlessly with its forest surroundings. The building was designed with a neutral carbon count, and the timber used was locally sourced, reflecting the natural landscape.

Prof Smith described the building as an educational invitation to visitors to ‘walk in our forest’ and learn new and sustainable ways of resourcing and building with timber. “The building behaves like a forest – the closer you get the more is revealed. Light filtering through its timber framework is also much like sunlight through a forest canopy – enhancing the building’s connection to its surroundings.” 

In discussing the Feather House, Prof Smith highlighted the importance of designing spaces that can evolve with their inhabitants. “Design for the ‘there and then’ rather than for the ‘here and now’,” he said. “One cannot design a room for every occasion, but you can provide an invitation.” He advocates for creating architecture that anticipates future changes and adapts to evolving environments, ensuring that buildings remain relevant and functional over time. His design philosophy underscores connection rather than division of spaces and doing less rather than more to create adaptable and sustainable living environments. “Do not design the space based on whose shoes are in the shoe rack,” he commented. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept